Penns Woods Bancorp (PWOD) 44.75 $PWOD Penns Woods

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Quantum BioPharma's $700 Million Lawsuit TORONTO, Quantum BioPharma Ltd. (NASDAQ: QNTM) has recently gained significant attention following its announcement of a major lawsuit against two of Canada's largest banks. This lawsuit, totaling USD $700 million, revolves around the allegation of stock market manipulation, a serious issue for any company trying to navigate the...

Boosting Industrial Growth Through E-Commerce A recent salon event aimed at promoting industrial development through cross-border e-commerce was held in Changsha County. This gathering highlighted the need to establish a clear pathway for developing industrial belts at the county level. Gathering of Industry Leaders The event attracted more than 100 representatives from a...

Central Garden & Pet's Q4 Earnings Highlights Central Garden & Pet (NASDAQ: CENT) has recently released its Q4 earnings report, providing valuable insights into its financial performance. Despite facing challenges, the company's latest results demonstrate resilience and potential for growth. Earnings Performance In the latest quarter, Central Garden & Pet exceeded...

European Buyers' Shanghai Pilgrimage Here's what's cooking in the sizzling world of furniture trade: come September, the focus shifts to Shanghai—the heart of Asia's manufacturing prowess. Furniture China and Maison Shanghai 2026 are gearing up to host a who's who of European retailers, distributors, importers, and designers for a duo of shows that promise an immersive...

Perle Joins the Solana Ecosystem to Enhance AI Development Perle, an innovative AI training data platform, has made a significant move by integrating into the Solana ecosystem. This aims to bridge human intelligence with AI models, a crucial aspect of improving AI systems. The integration signifies a pivotal moment for Perle as it aspires to enhance AI's overall training...